9. Cyriax J (1977) Deep massage. Physiotherapy 63(2):60–61
10. Dejung B, Gröbli C, Colla F, Weissmann R (2003) TriggerpunktTherapie. 1. Aufl. Huber, Bern
11. Dommerholt J, Bron C, Franssen J (2006) Myofascial trigger points: an evidence-informed
review. J Manu Manipul Ther 14(4):203–221
12. Dorsher PT (2008) Can classical acupuncture points and trigger points be compared in the
treatment of pain disorders? Birch’s analysis revisited. J Altern Complement Med 14(4):353–359
13. Dorsher PT (2009) Myofascial referred-pain data provide physiologic evidence of
acupuncture meridians. J Pain 10(7):723–731
14. Fleckenstein J, Zaps D, Ruger LJ et al (2010) Discrepancy between prevalence and perceived effectiveness of treatment methods in myofascial pain syndrome: results of a cross-sectional, nationwide survey. BMC Musculoskelet Disord 11:32
15. Frost FA, Jessen B, SiggaardAndersen J (1980) A control, double-blind comparison
of mepivacaine injection versus saline injection for myofascial pain. Lancet 1(8167):499–500
16. Ge HY, Fernandez-de-lasPenas C, Arendt-Nielsen L (2006) Sympathetic facilitation of hyperalgesia-evoked from myofascial tender and trigger points in patients with unilateral shoulder pain. Clin Neurophysiol 117(7):1545–1550
17. Gerdesmeyer L, Weil L Jr (2007) Extracorporeal shockwave therapy. Data Trace Publishing
Company, Towson
18. Gerdesmeyer L, Wagenpfeil S, Haake M et al (2003) Extracorporeal shock wave therapy
for the treatment of chronic calcifying tendonitis of the rotator cuff: a randomized controlled trial. JAMA 290(19):2573–2580
19. Gleitz M (2003) Stosswellen zur Behandlung myofaszialer Schmerzen in der Orthopädie: Eineneue Therapiemöglichkeit. Paper presented at the 51. Jahrestagung der Vereinigung Süddeutscher Orthopäden e. V
20. Gleitz M (2011) Myofasziale Syndrome und Triggerpunkte – Stoßwellentherapie in der Praxis. 1. Aufl. Level-10-Buchverlag Daniela Bamberg, Heilbronn
21. Gleitz M, Rädel R (2008) Die orthopädische Stosswellentherapie bei myofaszialen Erkrankungen. MOT 4:218–223
22. Gleitz M, Dreisilker U, Rädel R (2006) Die Orthopädische TriggerStosswellen-Therapie mit radialen und fokussierten Stosswellen: Eine Standortbestimmung. Orthop Praxis
42(5):303–312
23. Gregor M, Zimmermann M (1972) Characteristics of spinal neurones responding to cutaneous myelinated and unmyelinated fibres. J Physiol 221(3):555–576
24. Gröbli C, Dejung B (2003) Nichtmedikamentöse Therapie myofaszialer Schmerzen. Schmerz 17: 475–480
25. Gunn C (1996) The Gunn approach to the treatment of chronic pain: IMS for myofascial pain of radiculopathic origin. 2nd edn. Churchill Livingstone, Edinburgh
26. Hägg G (2003) The Cinderella hypothesis. In: Johannson H et al.
(eds) Chronic work-related myalgia. Gävle University Press, Gävle, Sweden, pp 127–32
27. Hausdorf J, Lemmens MA, Heck KD et al (2008a) Selective loss of unmyelinated nerve fibers after extracorporeal shockwave application to the musculoskeletal
system. Neuroscience 155(1):138–144
28. Hausdorf J, Lemmens MA, Kaplan S et al (2008b) Extracorporeal shockwave
application to the distal femur of rabbits diminishes the number of neurons immunoreactive for substance P in dorsal root ganglia L5. Brain Res 1207:96–101
29. Hong CZ, Chen Y, Twehous D (1996) Pressure threshold for referred pain by compression on the trigger point and adjacent areas. J Musculoskelet Pain 4(3):61–79
30. Hsieh CY, Hong CZ, Adams AH et al (2000) Interexaminer reliability of the palpation of trigger points in the trunk and lower limb muscles. Arch Phys Med Rehabil 81(3):258–
264
31. Ingber DE (2006) Cellular mechanotransduction: putting all the pieces together again. Faseb J 20(7): 811–827
32. Irnich D (2009) Leitfaden Triggerpunkte. Urban & Fischer Elsevier, München
33. Itoh K, Katsumi Y, Hirota S, Kitakoji H (2007) Randomised trial
of trigger point acupuncture compared with other acupuncture for treatment of chronic neck pain. Ther Med 15(3):172–179
34. Jaalouk DE, Lammerding J (2009) Mechanotransduction gone awry. Nat Rev Mol Cell Biol
10(1):63–73
35. Kalichman L, Vulfsons S (2010) Dry needling in the management of musculoskeletal pain. J Am Board Fam Med 23(5):640–646
36. Kamanli A, Kaya A, Ardicoglu O et al (2005) Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int 25(8):604–611
37. Kraus M, Reinhart E, Krause H, Reuther J (1999) Low energy extracorporeal shockwave therapy (ESWT) for treatment of myogelosis of the masseter muscle. Mund Kiefer Gesichtschir 3(1):20–23
38. Kuo YR, Wang CT, Wang FS et al (2009) Extracorporeal shockwave therapy enhanced wound healing via increasing topical blood perfusion and tissue regeneration in
a rat model of STZ-induced diabetes. Wound Repair Regen 17(4):522–530
39. Lange M (1931) Die Muskelhärten (Myogelosen). Lehmann’s, München
40. Lewit K (1987) Chain reactions in functional disorders of the locomotor system. Cas Lek Cesk 126(42):1310–1312
41. Lohse-Busch H, Kraemer M, Reime U (1997) A pilot investigation into the effects
of extracorporeal shock waves on muscular dysfunction in children with spastic movement disorders. Schmerz 11(2):108–112
42. Lucas N, Macaskill P, Irwig L et al (2009) Reliability of physical examination for diagnosis of
myofascial trigger points: a systematic review of the literature. Clin J Pain 25(1):80–89
43. Maier M, Averbeck B, Milz S et al (2003) Substance P and prostaglandin E2 release after
shock wave application to the rabbit femur. Clin Orthop Relat Res 406:237–245
44. Mariotto S, Prati AC de, Cavalieri E et al (2009) Extracorporeal shock wave therapy in inflammatory diseases: molecular mechanism that triggers antiinflammatory action. Curr Med
Chem 16(19):2366–2372
45. Melzack R, Stillwell DM, Fox EJ (1977) Trigger points and acupuncture points for pain:
correlations and implications. Pain 3(1):3–23
46. Mense S, Simons DG (2001) Muscle pain: understanding its nature, diagnosis, and treatment. Lippincott Williams & Wilkins, Philadelphia
47. Müller-Ehrenberg H (2005) Diagnose und Therapie myofaszialer Schmerzsyndrome mit
fokussierten Stosswellen. MOT 5:1– 6
48. Myburgh C, Larsen AH, Hartvigsen J (2008) A systematic, critical review of manual palpation for identifying myofascial trigger points: evidence and clinical significance. Arch Phys Med Rehabil 89(6):1169–1176
49. Neuland H, Duchstein H, Mei W (2004) Grundzüge der molekularbiologischen
Wirkung der extrakorporalen Stosswellen am menschlichen Organismus – In-vitro- und In-vivoUntersuchung. Orthop Praxis 40(9):488–492
50. Otten E (1988) Concepts and models of functional architecture in skeletal muscle. Exerc Sport Sci Rev 16:89–137
51. Pettrone FA, McCall BR (2005) Extracorporal shock wave therapy without local anesthesia for chronic lateral epicondylitis. J Bone Joint Surg [Am] 87(6):1297–1304
51. Pettrone FA, McCall BR (2005) Extracorporal shock wave therapy without local anesthesia for chronic lateral epicondylitis. J Bone Joint Surg [Am] 87(6):1297–1304
52. Porta M (2000) A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headache. Curr Rev Pain 4(1):31–35
53. Reilich P, Gröbli C, Dommerholt J (2012) Myofasziale Schmerzen und Triggerpunkte. 1. Aufl. Urban & Fischer Elsevier, München
54. Reitinger A, Radner H, Tilscher H et al (1996) Morphologische Untersuchung an Triggerpunkten. Man Med 34:256–262
55. Rompe JD (2002) Shock wave applications in musculoskeletal disorders. Thieme, Stuttgart New York
56. Rompe JD, Decking J, Schoellner C, Nafe B (2003) Shock wave application for chronic plantar fasciitis in running athletes. A prospective, randomized, placebocontrolled trial. Am J Sports Med 31(2):268–275
57. Ruch T (1949) Visceral sensation and referred pain. In: Fulton J (ed) Howell’s textbook of physiology. 16th edn. Saunders, Philadelphia, pp 385–401
58. Salaffi F, De Angelis R, Grassi W et al (2005) Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The Mapping Study. Clin Exp Rheumatol 23(6):819–828
59. Schaden W, Thiele R, Kolpl C et al (2007) Shock wave therapy for acute and chronic soft tissue wounds: a feasibility study. J Surg Res 143(1):1–12
60. Schoser B (2008) Muskel und Schmerz – Ein Leitfaden für die Differentialdiagnose und Therapie. 1. Aufl. Uni-Med, Bremen
61. Shah JP, Danoff JV, Desai MJ et al (2008) Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil 89(1):16–23
62. Shah JP, Phillips TM, Danoff JV, Gerber LH (2005) An in vivo microanalytical technique for measuring the local biochemical milieu of human skeletal muscle. J Appl Physiol 99(5):1977–1984
63. Sikdar S, Ortiz R, Gebreab T et al (2010) Understanding the vascular environment of myofascial trigger points using ultrasonic imaging and computational modeling. Conf Proc IEEE Eng Med Biol Soc 2010:5302–5305
64. Simons DG (1996) Clinical and etiological update of myofascial pain from trigger points. J Musculoskele Pain 4:97–125
65. Simons DG (2004) Review of enigmatic MTrPs as a common cause of enigmatic musculoskeletal pain and dysfunction. J Electromyogr Kinesiol 14(1):95–107
66. Simons DG, Travell J, Simons LS (1999) Travell and Simons‘ myofascial pain and dysfunction: the trigger point manual (upper half of body). 2nd edn, vol 1. Williams & Wilkins, Baltimore
67. Skovron ML (1992) Epidemiology of low back pain. Bailliéres Clin Rheumatol 6(3):559–573
68. Takahashi N, Wada Y, Ohtori Set al (2003) Application of shock waves to rat skin decreases calcitonin gene-related peptide immunoreactivity in dorsal root ganglion neurons. Auton Neurosci 107(2):81–84
69. Tough EA, White AR, Cummings TM et al (2009) Acupuncture and dry needling in the management of myofascial trigger
point pain: a systematic review and meta-analysis of randomised controlled trials. Eur J Pain 13(1):3–10
70. Tough EA, White AR, Richards S, Campbell J (2007) Variability of criteria used to diagnose myofascial
trigger point pain syndrome – evidence from a review of the literature. Clin J Pain 23(3):278–286
71. Travell J, Simons DG (1983) Myofascial pain and dysfunction. The trigger point manual. The upper
extremities, vol 1. Williams & Wilkins, Baltimore
72. Travell J, Simons DG (1992) Myofascial pain and dysfunction. The trigger point manual. The lower extremities, vol 2. Williams & Wilkins, Baltimore
73. Travell J, Rinzler S, Herman M (1942) Pain and disabiliy of the shoulder and arm: treatment by intramuscular infiltration with procaine hydrochloride. JAMA 120:427–432
74. Venancio Rde A, Alencar FG, Zamperini C (2008) Different substances and dry-needling injections in patients with myofascial pain and headaches. Cranio 26(2):96–103
75. Wall PD, Cronly-Dillon JR (1960) Pain, itch, and vibration. Arch Neurol 2:365–375
76. Wang CJ (2003) An overview of shock wave therapy in musculoskeletal disorders. Chang Gung Med J 26(4):220–232
77. Windisch A, Reitinger A, Traxler H et al (1999) Morphology and histochemistry of myogelosis. Clin Anat 12(4):266–271
78. Zhang T, Adatia A, Zarin W et al (2011) The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: a systematic review and meta analysis. Inflammopharmacology 19(1):21–34
79. Zieglgänsberger W, Berthele A, Tolle TR (2005) Understanding neuropathic pain. CNS Spectr 10(4):298–308
80. Zimpfer D, Aharinejad S, Holfeld J et al (2009) Direct epicardial shock wave therapy improves ventricular function and induces angiogenesis in ischemic heart failure. J Thorac Cardiovasc Surg 137(4):963–970